Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 20 Jul 2022 for SpringWorks Therapeutics, Inc., €87k. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Michael F. Burgess: trading record in brief
This profile gathers the share dealings of Michael F. Burgess in SpringWorks Therapeutics, Inc. Over a trading history stretching from 1 June 2021 to 18 July 2022, the count stands at 4 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The latest filing, published on 20 July 2022, reports a share grant of €87k in SpringWorks Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Michael F. Burgess
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
3,103 shares@ US$28.4763.9% of flowCommon StockSEC:0001104659-22-081241:0
2,672 shares@ US$19.6136.1% of flowCommon StockSEC:0001104659-22-077447:0
15,674 sharesCommon StockSEC:0001104659-22-002741:0
27,500 shares0Common StockSEC:0001104659-21-075168:0
4 of 4 declarations
